Patients with COVID-19 predominantly have a respiratory tract infection and acute lung
failure is the most severe complication. While the molecular basis of SARS-CoV-2 …

Uncontrolled inflammatory responses play a critical role in coronavirus disease (COVID-19).
In this context, because the triggering-receptor expressed on myeloid cells-1 (TREM-1) is …

Lipid and cholinergic mediators are inflammatory regulators, but their role in the immunopathology
of COVID-19 is still unclear. Here, we used human blood and tracheal aspirate (TA) to …

SARS-CoV-2 infection triggers distinct patterns of disease development characterized by
significant alterations in host regulatory responses. Severe cases exhibit profound lung …

COVID-19 is associated with a dysregulated immune response. Currently, several medicines
are licensed for the treatment of this disease. Due to their significant role in inhibiting pro-…

The non-classical histocompatibility antigen G (HLA-G) is an immune checkpoint molecule
that has been implicated in viral disorders. We evaluated the plasma soluble HLA-G (sHLA-G…

Background Sex-determined differences are rarely addressed in the management of diseases,
despite well-known contrasting outcomes between female and male patients. In COVID-…

COVID‐19 has a broad spectrum of clinical manifestations associated with the host immune
response heterogeneity. Despite the advances in COVID‐19 research, it is still crucial to …

Cytokine storms and hyperinflammation, potentially controlled by glucocorticoids, occur in
COVID-19; the roles of lipid mediators and acetylcholine (ACh) and how glucocorticoid …

Background The uncontrolled inflammatory response plays a critical role in the novel coronavirus
disease (COVID-19) and triggering receptor expressed on myeloid cells-1 (TREM-1) is …